Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 48
- 试验地点
- 2
- 主要终点
- Feasibility of the Hematolo-GIST intervention among hematologists and participants
研究概览
简要总结
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Currently a an MSK provider caring for patients with DLBCL (including DLBCL-transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL) which are histologically similar and treated as large-cell lymphoma)
- •Per medical record, is currently being treated by a provider who is participating in this study (for the purposes of this study, "treating provider" will be defined as any provider who provides care related to the patient's lymphoma diagnosis)
- •Per medical record, has a diagnosis of DLBCL including DLBCL-transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL) which are histologically similar and clinically treated as large-cell lymphoma
- •Per medical record, relapse/ refractory disease within 12 months of 4 cycles of first line therapy OR relapse after 2 cycles of later line therapy or or autologous stem cell transplant (ASCT)
- •Self-identify as Black and/or White
- •Per medical record, 18 years of age or older
- •Per self-report, fluent in English**
- •Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify English fluency necessary for participation in the study:
- •How well do you speak English? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- •What is your preferred language for healthcare? (must respond English)
排除标准
- •Per self-report, planning to leave the cancer center in the next 12 months
- •Cognitively impaired as demonstrated by (Blessed Orientation- Memory- Concentration (BOMC) score of ≥ 11
- •Per research staff judgment and/or self-report, too ill or weak to complete study procedures
- •Per medical record or self-report, receiving hospice care at the time of enrollment
研究组 & 干预措施
Hematologists
Hematologists will be recruited from the lymphoma clinics at MSK
干预措施: Hematolo-GIST Training (Behavioral)
Participants Patients
Participant patients are being treated by a hematologic oncologist participating in this study
干预措施: Participants Appointment (Behavioral)
结局指标
主要结局
Feasibility of the Hematolo-GIST intervention among hematologists and participants
时间窗: Up to 1 year
Feasbility is defined as ≥70% of screened eligible hematologists and participants enrolling in the study and ≥80% of hematologists learning the approach
次要结局
未报告次要终点
